The work of a chemistry professor at the University of Wisconsin-Milwaukee is helping to blaze the trail of reducing the United States’ dependence on foreign countries for vital medical isotopes. 

Hybrid PET/CT enhanced with intravenous CT contrast deserves wider acceptance and adoption, as diagnostically optimized CT can complement PET—and vice versa—for a variety of potential indications. That’s one opinion on the matter.

Randall Thompson, MD, immediate past president of the American Society of Nuclear Cardiology (ASNC), explains two key advances in cardiac nuclear imaging.
 

Brain MRI of the choroid plexus, the main supplier of cerebrospinal fluid, can deliver independent biomarkers for Alzheimer’s disease without an assist from clinical tests for amyloid abnormality or neurodegeneration. 

For 45% to 47% of patients who were deemed negative after conventional baseline scans, the use of the radiohybrid imaging agent resulted in at least one true positive PET finding

The first image of the black hole at the heart of our Milky Way galaxy amazed the scientific community, but left cardiologists with questions about the true cardiac health of the galaxy.

The study, which followed 195 patients recently diagnosed with multiple myeloma (MM), found that a negative PET/CT scan six months after diagnosis and induction therapy was significantly linked with improved survival.

The new equipment, which initially will be used to treat prostate and neuroendocrine tumors, is expected to be operational in July.